Financials

Company Total

  • Sales

    ( unit : KRW100mn )

    Sales : 2011(1,172.0), 2012(1,412.6), 2013(1,396.1), 2014(1,306.3)

  • Operating profit

    ( unit : KRW100mn )

    Operating profit : 2011(137.9), 2012(223.2), 2013(183.4), 2014(94.0)

( unit : KRW100mn )

Sales, Operating profit, (OP margin)
Classification 2011 2012 2013 2014 2015
Company Total Sales 1,172.0 1,412.6 1,396.1 1,306.3 1,211.8
Operating profit 137.9 223.2 183.4 94.0 26.6
(OP margin) 11.8% 15.8% 13.1% 7.2% 1.8%

Pharmaceutical

  • Sales

    ( unit : KRW100mn )

    Pharmaceutical business

  • Operating profit

    ( unit : KRW100mn )

    Pharmaceutical business

( unit : KRW100mn )

Sales, Operating profit, (OP margin)
Classification 2011 2012 2013 2014 2015
Pharmaceutical Sales 523.0 721.2 707.3 576.2 508.4
Active pharmaceutical ingredient 466.4 652.2 630.6 534.0 492.3
pharmaceutical intermediate 56.6 68.9 76.7 42.2 16.1
Operating profit 172.9 252.1 224.1 131.9 28.4
(OP margin) 33.1% 35.0% 31.7% 22.9% 5.6%

Eco-Chemicals

  • Sales

    ( unit : KRW100mn )

    Environmental business

  • Operating profit

    ( unit : KRW100mn )

    Environmental business

( unit : KRW100mn )

Sales, Operating profit, (OP margin)
Classification 2011 2012 2013 2014 2015
Eco-Chemicals Sales 649.0 691.4 688.9 730.1 703.4
Antimicrobial 285.1 288.7 301.5 348.2 367.3
Water Solutions 287.5 332.4 335.9 351.2 318.3
Other 76.4 70.2 51.5 30.6 17.6
Operating profit 4.4 17.0 14.1 16.8 41.5
(OP margin) 0.7% 25.% 2.1% 2.3% 5.9%
Bio R&D Cost 재무실적
Classification 2011 2012 2013 2014 2015
Bio R&D Cost 39.4 46.0 54.8 54.8 88.4